UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011028 |
|---|---|
| Receipt number | R000012911 |
| Scientific Title | Phase II, randomized, placebo-controlled study of docetaxel in combination with a mixed 20 peptides vaccine in patients with castration-resistant prostate cancer (CRPC) |
| Date of disclosure of the study information | 2013/07/01 |
| Last modified on | 2015/11/17 11:03:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/06/24 17:46:52 | ||
| 2 | Update | 2013/06/25 17:55:59 | Interventions/Control_1 Interventions/Control_2 |
|
| 3 | Update | 2013/06/25 17:59:34 | Organization1 |
|
| 4 | Update | 2013/06/25 18:13:51 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria |
|
| 5 | Update | 2013/07/05 09:12:02 | Recruitment status |
|
| 6 | Update | 2015/11/17 11:03:44 | Recruitment status |
